Resiliency Intervention for Patients With ALS and Their Care-Partners
Part of paid clinical trials in Boston, Massachusetts.
- Sponsor
- Massachusetts General Hospital
- Study ID
- NCT06968468
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Amyotrophic Lateral Sclerosis (ALS)
- Emotional Distress
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Resilient Together ALS — BEHAVIORALThis intervention will teach resiliency and coping skills (mindfulness, meaning making, etc) to dyads soon after ALS diagnosis in order to manage distress associated with an ALS diagnosis. These sessions will take place over Zoom with both the person diagnosed with ALS and their primary informal caregiver.
Study Details
The purpose of this study is to pilot a resiliency and coping intervention for persons recently diagnosed with Amyotrophic Lateral Sclerosis (ALS) and their primary informal caregivers. The data investigators gather in this study will be used to further refine our intervention.
Key Dates
- Start date
- May 13, 2026
- Status verified
- Nov 2025
- Primary completion
- Feb 13, 2027
- Completion
- Feb 28, 2027
Study Design
- Enrollment
- 20 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: RT-ALS InterventionDyads will participate in 6 30-45-minute skills based sessions. A clinical psychologist will deliver all sessions. The main intervention goal is to provide dyads with coping and resiliency skills and resources to reduce emotional distress, prevent chronic distress, and preserve quality of life for both dyad members as ALS progresses.
Primary Outcome Measure
Recruitment Feasibility [ Time Frame: 0 weeks ]
Central Contacts
- Christina Rush, PhD617-643-7641
- Morgan Seward, BA
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | - |
Find similar trials in Boston, MA
By research site
Related Studies
- Building Resiliency in Dyads of Patients With an ANI Admitted to the Neuro-ICU and Their Informal CaregiversRecruiting · Massachusetts General Hospital · Boston, Massachusetts
- Safety Study of XT-150 in Participants With ALSPHASE1 · Not Yet Recruiting · Xalud Therapeutics, Inc. · Phoenix, Arizona
- Efficacy and Safety of MSC-NTF (NurOwn) in Participants With Early Symptomatic ALS and Moderate Disease Presentation in ALS (ENDURANCE STUDY)PHASE3 · Not Yet Recruiting · Brainstorm-Cell Therapeutics · Phoenix, Arizona
- Mind-body Resilience Program for Cardiac Arrest Survivors and Their Caregivers: Recovering Together After Cardiac ArrestRecruiting · Massachusetts General Hospital · Boston, Massachusetts